Frequency of Dysphonia in Asthmatic Patients

NCT ID: NCT01999855

Last Updated: 2018-08-27

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Clinical Phase

NA

Total Enrollment

137 participants

Study Classification

INTERVENTIONAL

Study Start Date

2013-12-31

Study Completion Date

2017-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

For many years, it is known that asthmatics have more often dysphonia. However, no study has so far analyzed the reality of dysphonia in asthmatic by making phoniatric tests.

The etiology of dysphonia in asthmatic remains controversial. Indeed, for a long time, inhaled corticosteroids have been considered as responsible for organic abnormalities of the vocal cords. We hypothesized that women with asthma have more often dysphonia, and that dysphonia is rather functional origin.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Asthmatic Patients and Control Group

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

SINGLE_GROUP

Primary Study Purpose

PREVENTION

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

control group

* the Phonatory Maximum Time
* Vocal Handicap Index
* Scale GRBAS of Hirano
* Videolaryngoscopy

Group Type ACTIVE_COMPARATOR

Phoniatric tests

Intervention Type OTHER

Asthmatic patients

* The Phonatory Maximum Time
* Vocal Handicap Index
* Scale GRBAS of Hirano
* Videolaryngoscopy

Group Type EXPERIMENTAL

Phoniatric tests

Intervention Type OTHER

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Phoniatric tests

Intervention Type OTHER

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

- the Phonatory Maximum Time - Vocal Handicap Index - Scale GRBAS of Hirano - Videolaryngoscopy

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Women
* Aged between 18 to 65 years
* Patient who signed the informed consent.
* affiliated with a social security system.

Patients with asthma (GINA criteria)

\- persistent asthma with inhaled corticosteroids.
Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University Hospital, Strasbourg, France

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Frédéric De Blay, Pr

Role: PRINCIPAL_INVESTIGATOR

Pôle de Pathologie Thoracique- Hôpitaux Universitaires Strasbourg

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Service de pneumologie, d'allergologie et de pathologie de l'environnement

Strasbourg, , France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

5517

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

ASTHMAXcel Voice Study
NCT06935084 RECRUITING NA